Tin tức & Cập nhật

Consuming ultraprocessed foods in large quantities can shorten the life expectancy of Asians, being associated with elevated risks of mortality from all causes, cardiovascular diseases, and respiratory diseases, as shown in a study from Singapore.

The hedgehog pathway inhibitor taladegib appears to improve outcomes in idiopathic pulmonary fibrosis (IPF) while having an acceptable safety profile, as shown in a phase IIa proof-of-concept trial.

The incidence of obstructive sleep apnoea (OSA) is higher on weekends than on weekdays, a study reports.

Antenatal administration of betamethasone in women with twin pregnancies at risk of late preterm delivery appears to reduce the risk of neonatal respiratory morbidity, as shown in a study.

A single dose of clesrovimab, a long-acting monoclonal antibody, significantly reduced the incidence of respiratory syncytial virus (RSV)-associated medically attended lower respiratory infections (LRIs) and hospitalizations in healthy infants, according to the phase IIb–III CLEVER trial.

A retrospective analysis suggests that traditional Chinese medicine (TCM) may be a suitable treatment alternative for post-COVID symptoms.

New drug applications approved by US FDA as of 1-15 August 2025 which includes New Molecular Entities (NMEs) and new biologics. It does not include Tentative Approvals. Supplemental approvals may have occurred since the original approval date.